Cardiac natriuretic peptides are a family of structurally related peptides that are important in
sodium and volume homeostasis. They consist of atrial natriuretic peptide, brain natriuretic …

When measured in ambulatory individuals with heart failure (HF), higher concentrations of N-
terminal pro–B-type natriuretic peptide (NT-proBNP) have been linked with HF severity and …

Natriuretic peptides play a crucial role in maintaining cardiovascular homeostasis. Among
their properties are vasodilation, natriuresis, diuresis, and inhibition of cardiac remodeling …

C-type natriuretic peptide (CNP) is a peptide produced by the vascular endothelium with
vasodilative properties. It shares structural and physiological properties with the atrial and …

Three types of natriuretic peptides (NP) have been isolated: atrial natriuretic peptide (ANP),
brain natriuretic peptide (BNP), and C-type natriuretic peptide (CNP). The NP family elicits a …

Testing for natriuretic peptides (BNP, NT-proBNP or MR-proANP) is recommended by the
European Society of Cardiology (ESC) since 2005 for the exclusion diagnosis of acute and …

While natriuretic peptide (NP) testing has gained widespread acceptance for the diagnosis
and prognosis of heart failure (HF), as well as risk stratification across the spectrum of …

Notwithstanding substantial improvements in diagnosis and treatment, Heart Failure (HF)
remains a major disease burden with high prevalence and poor outcomes worldwide …

The natriuretic peptides–atrial, brain and C-type–were discovered during the last twenty
years. Their effects on cardiovascular, renal, cerebral and other tissues through guanylyl …

The discovery of atrial, brain, and C-type natriuretic peptides (ANP, BNP, and CNP) and their
cognate receptors has greatly increased our knowledge of the control of hypertension and …